Intraocular inflammation more common with aflibercept injections in real-world setting
The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to a study published online May 1 in JAMA Ophthalmology.
May 9, 2025
0
0